Chronic Pain Types What Is Complex Regional Pain Syndrome (CRPS)? By Carol Eustice Carol Eustice Facebook Carol Eustice is a writer covering arthritis and chronic illness, who herself has been diagnosed with both rheumatoid arthritis and osteoarthritis. Learn about our editorial process Updated on May 23, 2022 Medically reviewed by Huma Sheikh, MD Medically reviewed by Huma Sheikh, MD Facebook LinkedIn Twitter Huma Sheikh, MD, is a board-certified neurologist, specializing in migraine and stroke, and affiliated with Mount Sinai of New York. Learn about our Medical Expert Board Print Table of Contents View All Table of Contents Symptoms Causes Diagnosis Treatments Prognosis Complex regional pain syndrome (CRPS) is characterized by excess pain and inflammation that is believed to be the result of dysfunction in the central or peripheral nervous systems. Older terms used to describe complex regional pain syndrome are: Reflex sympathetic dystrophy (RSD) Causalgia - burning pain due to damaged perhipheral nerve Causalgia was a term first used during the Civil War to describe the intense, hot pain felt by some veterans long after their wounds had healed. There are two types of CRPS. The first, CRPS I is frequently triggered by tissue injury, but with no underlying nerve injury (previously known as RSD). People with CRPS II experience the same symptoms but their cases are clearly associated with a nerve injury (previously known as causalgia). CPRS can strike at any age but is considered rare in children and adolescents, and is more common in middle and late adulthood. It affects women three to four times as much as men. Symptoms The key symptom of CRPS is continuous, intense pain out of proportion to the severity of the injury (if an injury has occurred), which gets worse rather than better over time. CRPS most often affects one of the extremities such as: ArmsLegsHandsFeet Complex regional pain syndrome is also often accompanied by: "Burning" painIncreased skin sensitivityChanges in skin temperature: warmer or cooler compared to the opposite extremityChanges in skin color: often blotchy, purple, pale, or redChanges in skin texture: shiny and thin, and sometimes excessively sweatyChanges in nail and hair growth patternsSwelling and stiffness in affected jointsMotor disability, with decreased ability to move the affected body part Often the pain spreads to include the entire arm or leg, even though the initiating injury might have been only to a finger or toe. Pain can sometimes even travel to the opposite extremity. It may be heightened by emotional stress. The symptoms of CRPS vary in severity and length. Some experts believe there are three stages associated with CRPS, marked by progressive changes in the skin, muscles, joints, ligaments, and bones of the affected area, although this progression has not yet been validated by clinical research studies. Stage one is thought to last from 1 to 3 months and is characterized by severe, burning pain, along with muscle spasm, joint stiffness, rapid hair growth, and alterations in the blood vessels that cause the skin to change color and temperature. Stage two lasts from 3 to 6 months and is characterized by intensifying pain, swelling, decreased hair growth, cracked, brittle, grooved, or spotty nails, softened bones, stiff joints, and weak muscle tone. In stage three the syndrome progresses to the point where changes in the skin and bone are no longer reversible. Pain becomes unyielding and may involve the entire limb or affected area. There may be marked muscle loss (atrophy), severely limited mobility, and involuntary contractions of the muscles and tendons that flex the joints. Limbs may become contorted. Causes Doctors aren’t sure what causes CRPS. There may be several possible triggers, including surgery, fracture. trauma induced inflammation, changes in the central nervous system (brain and spinal cord) that alter the perception of pain, autoimmune processes, alterations to the sympathetic nervous system, and more. In some cases, the sympathetic nervous system plays an important role in sustaining the pain. The most recent theories suggest that pain receptors in the affected part of the body become responsive to a family of nervous system messengers known as catecholamines. Animal studies indicate that norepinephrine, a catecholamine released from sympathetic nerves, acquires the capacity to activate pain pathways after tissue or nerve injury. Some experts believe that the importance of the catecholamines varies depending on the stage of the disease. Another theory is that CRPS is caused by a triggering of the immune response, which leads to the characteristic inflammatory symptoms of redness, warmth, and swelling in the affected area. CRPS may, therefore, represent a disruption of the healing process. In all likelihood, CRPS does not have a single cause but is rather the result of multiple causes that produce similar symptoms. Diagnosis CRPS is diagnosed primarily through observation of the signs and symptoms. But because many other conditions have similar symptoms, it can be difficult for doctors to make a firm diagnosis of CRPS early in the course of the disorder when symptoms are few or mild. Or, for example, a simple nerve entrapment can sometimes cause pain severe enough to resemble CRPS. Diagnosis is further complicated by the fact that some people will improve gradually over time without treatment. Since there is no specific diagnostic test for CRPS, the most important role for testing is to help rule out other conditions. Some clinicians will begin wiht a few simple tests, such as applying a stimulus to the area to see if it causes pain such as touch, pinpricks, heat, and cold. Another method is simply having patients draw the outline of their most abnormal skin which often reveals the affected nerve. Some doctors will order a variety of tests including: Nerve conduction studies detect some, but not all, CRPS-associated nerve injuriesUltrasound or magnetic resonance neurography (MRN), to reveal underlying nerve damage.Triple-phase bone scans to identify changes in the bone and in blood circulation. Treatments Because there is no cure for complex regional pain syndrome, treatment is aimed at relieving painful symptoms so that people can resume their normal lives. The following therapies are often used: Physical therapy: A gradually increasing physical therapy or exercise program to keep the painful limb or body part moving may help restore some range of motion and function. Psychotherapy: CRPS often has profound psychological effects on people and their families. Those with CRPS may suffer from depression, anxiety, or post-traumatic stress disorder, all of which heighten the perception of pain and make rehabilitation efforts more difficult. Sympathetic nerve block: Some patients will get significant pain relief from sympathetic nerve blocks. Sympathetic blocks can be done in a variety of ways. One technique involves the intravenous administration of phentolamine, a drug that blocks sympathetic receptors. Another technique involves the placement of an anesthetic next to the spine to directly block the sympathetic nerves. Medications: No single drug or combination of drugs has produced consistent long-lasting improvement in symptoms. Many different classes of medication are used to treat CRPS, including antiseizure drugs, antidepressants, corticosteroids, opioids, and topical analgesic drugs that act locally on painful nerves, skin, and muscles. Surgical sympathectomy: The use of surgical sympathectomy, a technique that destroys the nerves involved in CRPS, is controversial. Some experts think it is unwarranted and makes symptoms worse; others report a favorable outcome. Sympathectomy should be used only in patients whose pain is dramatically relieved (although temporarily) by selective sympathetic blocks. Spinal cord stimulation: The placement of stimulating electrodes next to the spinal cord provides a pleasant tingling sensation in the painful area. This technique appears to help many patients with their pain. Intrathecal drug pumps: These devices administer drugs directly to the spinal fluid so that opioids and local anesthetic agents can be delivered to pain-signaling targets in the spinal cord at doses far lower than those required for oral administration. This technique decreases side effects and increases drug effectiveness. Prognosis The prognosis for CRPS varies from person to person. Spontaneous remission from symptoms occurs in certain people. Others can have unremitting pain and crippling, irreversible changes in spite of treatment. Some doctors believe that early treatment is helpful in limiting the disorder, but this belief has not yet been supported by evidence from clinical studies. More research is needed to understand the causes of CRPS, how it progresses, and the role of early treatment. 8 Sources Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy. National Institute of Neurological Disorders and Stroke. Complex regional pain syndrome fact sheet. Goh EL, Chidambaram S, Ma D. Complex regional pain syndrome: A recent update. Burns Trauma. 2017;5:2. doi:10.1186/s41038-016-0066-4 National Organization for Rare Disorders. Complex regional pain syndrome. de Mos M, de Bruijn AGJ, Huygen FJPM, Dieleman JP, Stricker ChBH, Sturkenboom MCJM. The incidence of complex regional pain syndrome: A population-based study. Pain. 2007;129(1):12-20.doi:10.1016/j.pain.2006.09.008 Stanford Medicine. Complex Regional Pain Syndrome (CRPS). Baron R, Schattschneider J, Binder A, Siebrecht D, Wasner G. Relation between sympathetic vasoconstrictor activity and pain and hyperalgesia in complex regional pain syndromes: A case–control study. Lancet. 2002;359(9318):1655–1660. doi:10.1016/S0140-6736(02)08589-6 Bruehl S. Complex regional pain syndrome. BMJ. 2015;351:h2730. doi:10.1136/bmj.h2730 Dubuis E, Thompson V, Leite MI, Blaes F, Maihofner C, Greensmith D, et al. Longstanding complex regional pain syndrome is associated with activating autoantibodies against alpha-1a adrenoceptors. Pain. 2014;155(11):2408–2417. doi:10.1016/j.pain.2014.09.022 By Carol Eustice Carol Eustice is a writer covering arthritis and chronic illness, who herself has been diagnosed with both rheumatoid arthritis and osteoarthritis. See Our Editorial Process Meet Our Medical Expert Board Share Feedback Was this page helpful? Thanks for your feedback! What is your feedback? Other Helpful Report an Error Submit